Name | Type | Posted | Actions |
|---|---|---|---|
36C24225Q1012.docx | DOCX | Aug 21, 2025 |
6550--Notice of Intent to Sole Source - Polymedco iFOBT
Contact and place of performance
Lindsay Goldsmith
Not specified
This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs (DVA), on behalf of VISN 02 Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to: Name of Contractor: Polymedco Cancer Diagnostic Products, LLC Street Address: 510 Furnance Dock Road City, State, Zip: Cortland Manor, NY 10567 VISN 2 medical centers have a recurrin...
View moreThe Department of Veterans Affairs (DVA), on behalf of VISN 02 Medical Centers, intends to award a firm-fixed-price sole source contract to Polymedco Cancer Diagnostic Products, LLC. This requirement covers Polymedco OC-Auto Fecal Immunochemical Test (FIT) kits used for colorectal cancer screening across the New York/New Jersey Healthcare Network. The anticipated award follows a determination that only one source is reasonably available to provide test kits compatible with existing Polymedco analyzers currently in use within VISN 02 facilities.
The selected system must meet specific clinical and logistical specifications, including automated analysis capable of detecting human hemoglobin without dietary restrictions and a specimen transport system stable for at least 14 days at ambient temperatures. Required components include mailing systems that meet US Postal Service requirements, analyzers with result printout capabilities, and equipment functional within laboratory humidity levels of 15 to 85 percent. The system must also include a 120-volt UPS with 2–3 hours of backup power, compatibility with multiple barcode formats such as Code 39 and Code 128, and sufficient validation to meet Clinical and Laboratory Standards Institute (CLSI) standards.
This special notice, identified by solicitation number 36C24225Q1012, is classified under NAICS 334516 Analytical Laboratory Instrument Manufacturing and PSC 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS. While this is not a request for quotes, the agency will consider capability statements from responsible sources received by September 3, 2025. Submissions must be directed to Contracting Officer Lindsay Goldsmith. One attachment, 36C24225Q1012.docx, was issued with the announcement on August 21, 2025.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.